CSAM Health displays many qualities of a serial acquirer set to create shareholder value. These qualities set them up to compound intrinsic value at 15-25% over the next decade.
Very difficult to place a value on this kind of company, but you have done a really good job of it. Too many assumptions need to be made, which is why buying it cheap is the only thing that can really help. Price to sales right now is still very high.
Do you have an idea of what proportion of management wealth is invested. I know you said 10% through Equilibrium...but what % of this is their total wealth?
I really appreciate your analysis. This stock is hard to evaluate. For me too risky. Would you like to cover in the coming weeks Lifco, Addtech, Judges Scientific and Lgercrantz?
thanks! any clue how it compares to the swiss stock Ascom? who would take over who between the two?